Open AccessEfficacy of Second-Line Antiretroviral Therapy Among People Living With HIV/AIDS in Asia
Author(s) -
David C. Boettiger,
Nguyen Vk,
Nicolas Durier,
Bui Hv,
Heng Sim Bl,
Iskandar Azwa,
Matthew Law,
Kiat Ruxrungtham
Publication year - 2015
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000000411
Subject(s) - lopinavir , atazanavir , medicine , viral load , ritonavir , confidence interval , hazard ratio , antiretroviral therapy , human immunodeficiency virus (hiv) , immunology
Roughly 4% of the 1.25 million patients on antiretroviral therapy (ART) in Asia are using second-line therapy. To maximize patient benefit and regional resources, it is important to optimize the timing of second-line ART initiation and use the most effective compounds available.